Protein Expression Market | Increasing Incidence of Chronic Diseases | Growing at a CAGR of 11.5%

PUNE, India, 2020-May-08 — /EPR Network/ —

[173 Pages Report] The Protein Expression Market was valued at USD 1,654.0 Million in 2017 and is expected to grow at a CAGR of 11.5% to reach USD 2,850.5 Million in 2022.

This report aims to provide insights into the global protein expression market. It provides valuable information regarding the market based on systems type, product, application and end user. Details on regional markets for these segments are also presented in this report. In addition, leading players in the market have been profiled to understand the strategies undertaken by them to be competitive in this market.

Protein expression is a technique or methodology in which proteins are characterized, modified, and synthesized in the host cells. The selected protein is typically achieved by the modification or alteration of the protein expression process in a living cell. Various kinds of protein expression systems are used for the production of a broad range of therapeutic proteins such as insulin, interferons, and interleukins.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

Market Dynamics:

Rising geriatric population;

The global population of individuals aged 60 years and above is expected to increase from 901 million in 2015 to 1.4 billion by 2030 (Source: UN Population Division). The physiological changes that occur with aging are responsible for the higher probability of elderly individuals developing chronic diseases, such as cancer. Thus, cancer incidence across the globe is expected to grow in line with the growth in aging population.

According to GLOBOCAN 2012, out of the 14.1 million new cancer patients in 2012, ~60.1% were individuals aged 60 years and above. Among males, the population aged 60 years and above is at a high risk of developing prostate cancer. For instance, ~84.1% of new prostate cancer cases in 2012 were found to be among the population aged 60 years and above (Source: GLOBOCAN 2012). Moreover, GLOBOCAN estimates that by 2025, the number of new cancer cases diagnosed per year will reach 19.3 million, mainly due to the rapid growth in the global geriatric population. As a result, this demographic trend is expected to drive the demand for radiotherapy procedures over the coming years.

Market Segmentation in Depth:

On the basis of systems type, the market is segmented into insect cell expression systems; mammalian cell expression systems; prokaryotic expression systems, yeast expression systems; cell-free expression systems; and algal-based expression systems. The prokaryotic expression systems segment is expected to account for the largest share of the market.

On the basis of product, the market is segmented into competent cells, expression vectors, instruments, reagents, and services. The reagents segment is expected to hold the largest market share of the protein expression market. This is primarily due to the increasing protein expression research activities and the large-scale production of antibodies and vaccines.

By application, the protein expression market is segmented into therapeutic applications, research applications and industrial applications. The therapeutic applications segment is expected to account for the largest share of the market.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

By region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe. However, the Asian region is expected to witness the highest growth during the forecast period. The presence of emerging economies like China and India; rising prevalence of chronic diseases are some of the key factors driving the high growth of this regional segment.

Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Takara Bio Inc. (Japan), Promega Corporation (U.S.), Genscript Biotech Corporation (China), and Agilent Technologies Inc. (U.S.) are the top six players in Protein Expression Market.